The U.S. Food and Drug Administration's mass layoffs included senior negotiators in talks with the pharmaceutical industry ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

For weeks, President Trump has made it clear that tariffs are going to be slapped on pharmaceuticals. But that is about the ...

Donald Trump's healthcare revamp, emphasizing generics and biosimilars, could boost Indian drug makers, who already supply 40 ...

Makary announced the change during his first interview as commissioner. He spent much of the conversation with Megyn Kelly ...

U.S. President Donald Trump directed his health department on Tuesday to work with Congress on revamping a law that allows ...

The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...

Pharmaceuticals are currently exempt from a baseline 10 per cent tax Mr Trump has placed on goods entering the US, but the US ...

Johnson & Johnson is holding its earnings outlook steady despite President Donald Trump moving decisively toward imposing tariffs on the pharmaceutical industry.

The executive order aims to lower prescription prices, but targets the mechanism for negotiating small molecule drug costs.

The pharmaceutical industry is bracing for chaos if President Trump follows through on his threat to impose “a major tariff” on prescription drug imports. Tariffs would disrupt ...